Detailed information for compound 1463226

Basic information

Technical information
  • TDR Targets ID: 1463226
  • Name: 5-chloro-N-[5-chloro-2-(2-methyl-5-propan-2-y lphenoxy)phenyl]-2-hydroxybenzamide
  • MW: 430.324 | Formula: C23H21Cl2NO3
  • H donors: 2 H acceptors: 2 LogP: 7.23 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: Clc1ccc(c(c1)NC(=O)c1cc(Cl)ccc1O)Oc1cc(ccc1C)C(C)C
  • InChi: 1S/C23H21Cl2NO3/c1-13(2)15-5-4-14(3)22(10-15)29-21-9-7-17(25)12-19(21)26-23(28)18-11-16(24)6-8-20(18)27/h4-13,27H,1-3H3,(H,26,28)
  • InChiKey: HAOZATDJHLNEBZ-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 5-chloro-N-[5-chloro-2-(5-isopropyl-2-methyl-phenoxy)phenyl]-2-hydroxy-benzamide
  • 5-chloro-N-[5-chloro-2-(5-isopropyl-2-methylphenoxy)phenyl]-2-hydroxybenzamide
  • 5-chloro-N-[5-chloro-2-(2-methyl-5-propan-2-yl-phenoxy)phenyl]-2-hydroxy-benzamide
  • AH-034/32474063
  • ZINC02024059

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Mycobacterium leprae PROBABLE REPLICATIVE DNA HELICASE DNAB replicative DNA helicase 0.1945 1 1
Trichomonas vaginalis hypothetical protein 0.1174 0.5843 0.5
Giardia lamblia Dual specificity phosphatase, catalytic 0.0166 0.0402 0.5
Loa Loa (eye worm) dual specificity phosphatase 0.0166 0.0402 0.1281
Schistosoma mansoni Replicative DNA helicase 0.1945 1 1
Echinococcus multilocularis dual specificity protein phosphatase 0.0166 0.0402 0.0459
Loa Loa (eye worm) twinkle helicase 0.0556 0.2506 1
Toxoplasma gondii enoyl-acyl carrier reductase ENR 0.1174 0.5843 1
Onchocerca volvulus 0.0166 0.0402 1
Echinococcus granulosus EGFP:Bcl2 fusion protein 0.1356 0.6823 1
Wolbachia endosymbiont of Brugia malayi replicative DNA helicase 0.1945 1 1
Mycobacterium ulcerans enoyl-(acyl carrier protein) reductase 0.1174 0.5843 0.5843
Mycobacterium ulcerans replicative DNA helicase DnaB 0.1945 1 1
Mycobacterium tuberculosis NADH-dependent enoyl-[acyl-carrier-protein] reductase InhA (NADH-dependent enoyl-ACP reductase) 0.1174 0.5843 0.5843
Mycobacterium tuberculosis Probable replicative DNA helicase DnaB 0.1945 1 1
Trypanosoma cruzi oxidoreductase-like protein, putative 0.0091 0 0.5
Echinococcus granulosus dual specificity protein phosphatase 0.0166 0.0402 0.0459
Plasmodium falciparum enoyl-acyl carrier reductase 0.1174 0.5843 0.5
Brugia malayi Dual specificity phosphatase, catalytic domain containing protein 0.0166 0.0402 1
Trypanosoma brucei oxidoreductase-like protein 0.0091 0 0.5
Echinococcus multilocularis EGFP:Bcl2 fusion protein 0.1356 0.6823 1
Leishmania major pteridine reductase 1 0.0091 0 0.5
Treponema pallidum replicative DNA helicase (dnaB) 0.1945 1 0.5
Leishmania major oxidoreductase-like protein 0.0091 0 0.5
Schistosoma mansoni dual specificity protein phosphatase 0.0166 0.0402 0.0312
Plasmodium vivax enoyl-acyl carrier protein reductase 0.1174 0.5843 1

Activities

Activity type Activity value Assay description Source Reference
MIC (functional) = 8 ug ml-1 Antimicrobial activity against Escherichia coli ATCC 29213 after 18 to 24 hrs by alamar blue assay ChEMBL. 21075637

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.